Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.30 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1147891 | 0.89 | CA4 (0.35) | CA4LMNATSHRALOX12ACHE | |
| SCHEMBL1679847 | 0.84 | CA4 (0.32) | CA4LMNATSHRALOX12ACHE | |
| SCHEMBL3682150 | 0.79 | CA4 (0.32) | CA4LMNATSHRALOX12ACHE | |
| SCHEMBL1147930 | 0.79 | CA4 (0.32) | CA4LMNATSHRALOX12ACHE | |
| SCHEMBL17328006 | 0.78 | CA4 (0.35) | CA4LMNATSHRALOX12ACHE | |
| SCHEMBL9901218 | 0.77 | CA4 (0.31) | CA4 | |
| SCHEMBL15283787 | 0.77 | CA4 (0.31) | CA4 | |
| SCHEMBL19469322 | 0.77 | CA4 (0.31) | CA4 | |
| SCHEMBL28758122 | 0.77 | CA4 (0.31) | CA4 | |
| SCHEMBL19927491 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250388769-A1 | Ink Composition, Package Structure and Semiconductor Device | HANGZHOU FIRST APPLIED MAT CO LTD (CN) | 2025-12-25 | — | — | US | disclosed |
| US-12497511-B2 | Crosslinkable organopolysiloxane compositions | WACKER CHEMIE AG (DE) | 2025-12-16 | — | — | US | disclosed |
| EP-4530321-A1 | INK COMPOSITION, PACKAGING STRUCTURE, AND SEMICONDUCTOR DEVICE | Hangzhou First Applied Material Co., Ltd. (CN) | 2025-04-02 | — | — | EP | disclosed |
| US-12187854-B2 | Crosslinkable organosiloxane compositions | WACKER CHEMIE AG (DE) | 2025-01-07 | — | — | US | disclosed |
| US-12110393-B2 | Crosslinkable organopolysiloxane compositions | WACKER CHEMIE AG (DE) | 2024-10-08 | — | — | US | disclosed |
| EP-3507104-B1 | PRODUCTION OF CIS-1,4-POLYDIENES WITH MULTIPLE SILANE FUNCTIONAL GROUPS PREPARED BYIN-SITU | BRIDGESTONE CORP (JP) | 2024-03-27 | — | — | EP | disclosed |
| CN-115109464-A | Ink composition, packaging structure and semiconductor device | 杭州福斯特应用材料股份有限公司 | 2022-09-27 | — | — | CN | disclosed |
| EP-3837317-B1 | CROSSLINKABLE ORGANOSILOXANE COMPOSITIONS | WACKER CHEMIE AG (DE) | 2022-04-20 | — | — | EP | disclosed |
| US-20210347952-A1 | CROSSLINKABLE ORGANOPOLYSILOXANE COMPOSITIONS | WACKER CHEMIE AG (DE) | 2021-11-11 | — | — | US | disclosed |
| CN-109641482-B | Preparation of cis-1, 4-polydienes having multiple silane functional groups prepared by in situ hydrosilylation of polymer glues | 株式会社普利司通 | 2021-11-05 | — | — | CN | disclosed |
| US-20210309856-A1 | CROSSLINKABLE ORGANOPOLYSILOXANE COMPOSITIONS | WACKER CHEMIE AG (DE) | 2021-10-07 | — | — | US | disclosed |
| US-20210238366-A1 | CROSSLINKABLE ORGANOSILOXANE COMPOSITIONS | WACKER CHEMIE AG (DE) | 2021-08-05 | — | — | US | disclosed |
| EP-3837304-A1 | CROSSLINKABLE ORGANOYSILOXANE COMPOSITIONS | Wacker Chemie AG (DE) | 2021-06-23 | — | — | EP | disclosed |
| EP-3837317-A1 | CROSSLINKABLE ORGANOSILOXANE COMPOSITIONS | Wacker Chemie AG (DE) | 2021-06-23 | — | — | EP | disclosed |
| CN-112996841-A | Crosslinkable organosiloxane compositions | 瓦克化学股份公司 | 2021-06-18 | — | — | CN | disclosed |
| US-10975178-B2 | Production of cis-1,4-polydienes with multiple silane functional groups prepared by in-situ hydrosilylation of polymer cement | BRIDGESTONE CORPORATION (JP) | 2021-04-13 | — | — | US | disclosed |
| WO-2020035151-A1 | CROSSLINKABLE ORGANOYSILOXANE COMPOSITIONS | WACKER CHEMIE AG (DE) | 2020-02-20 | — | — | WO | disclosed |
| WO-2020035149-A1 | CROSSLINKABLE ORGANOYSILOXANE COMPOSITIONS | WACKER CHEMIE AG (DE) | 2020-02-20 | — | — | WO | disclosed |
| US-20190211120-A1 | Production Of Cis-1,4-Polydienes With Multiple Silane Functional Groups Prepared By In-Situ Hydrosilylation Of Polymer Cement | BRIDGESTONE CORPORATION (JP) | 2019-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250388769-A1 | Ink Composition, Package Structure and Semiconductor Device | ASH2L, INO80C, CCNL2 | CA4 2836/4885LMNA 2409/4885TSHR 4295/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.